United Kingdom

Motif Bio PLC (MTFB.OQ)

MTFB.OQ on NASDAQ Stock Exchange Capital Market

18 Jan 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Motif Bio plc is a clinical-stage biopharmaceutical company. The Company is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It operates in the development and commercialization of pharmaceutical formulations segment. The Company is focused on... (more)


Beta: --
Market Cap(Mil.): £118.90
Shares Outstanding(Mil.): 263.13
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 85.70 16.58
EPS (TTM): -- -- --
ROI: -- 3.19 10.60
ROE: -- 4.52 14.19

BRIEF-Motif Bio Files For Mixed Shelf Of Up To $80 Million

* FILES FOR MIXED SHELF OF UP TO $80 MILLION - SEC FILING Source text: (http://bit.ly/2DqhH7L) Further company coverage:

18 Jan 2018

BRIEF-Motif Bio Plc To Offer And Sell Up To 1.2 Mln ADR

* MOTIF BIO PLC FILES FOR OFFER AND SALE OF UP TO 1.2 MILLION AMERICAN DEPOSITARY SHARES - SEC FILING Source text for Eikon: (http://bit.ly/2CfPXz9) Further company coverage:

13 Dec 2017

BRIEF-Motif Bio secures up to US$20 million debt financing

* ‍Company has entered into an agreement for up to US$20 million in debt financing with Hercules Capital, Inc​

15 Nov 2017

Earnings vs. Estimates